Balance Sheet Northrop Grumman Corporation

Stocks

NOC

US6668071029

Aerospace & Defense

Market Closed - NYSE Other stock markets 21:00:02 17/07/2026 BST			Pre-market 11:39:08
521.57 ^USD	+0.56%		525.50	+0.75%

09:39am	MBDA unveils interceptor to counter mass drone attacks	RE
07-15	Northrop Grumman, Airbus Collaborate to Bolster NATO's Force Fleet With MQ-4C Triton UAV	MT

f673a081e8ebd0be6e8b14113a.GeBwXc2iZdBDQJoN8O2OF7WN-GczNAVNdN54EeQG9Yw.fqgDDpTvJIYFcfJ9m7jXfu_4p1JmV2ccNa5PctFhh7532RNui_0skXst8Q

Published financial data: NORTHROP GRUMMAN CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	35.67B	36.6B	39.29B	41.03B	41.95B
Total Revenues	35.67B	36.6B	39.29B	41.03B	41.95B
Cost of Goods Sold, Total	28.4B	29.13B	32.74B	32.67B	33.64B
Gross Profit	7.27B	7.47B	6.55B	8.36B	8.31B
Selling General & Admin Expenses, Total	-227M	1.14B	3.91B	2.89B	2.96B
Other Operating Expenses, Total	-227M	1.14B	3.91B	2.89B	2.96B
Operating Income	7.5B	6.34B	2.64B	5.47B	5.35B
Interest Expense, Total	-556M	-506M	-545M	-621M	-665M
Net Interest Expenses	-556M	-506M	-545M	-621M	-665M
Other Non Operating Income (Expenses)	73M	4M	149M	168M	109M
EBT, Excl. Unusual Items	7.01B	5.84B	2.25B	5.02B	4.79B
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	97M	-	45M
Gain (Loss) On Sale Of Assets	1.98B	-	-	-	231M
Other Unusual Items	-54M	-	-	-	-
EBT, Incl. Unusual Items	8.94B	5.84B	2.35B	5.02B	5.07B
Income Tax Expense	1.93B	940M	290M	842M	886M
Earnings From Continuing Operations	7B	4.9B	2.06B	4.17B	4.18B
Net Income to Company	7B	4.9B	2.06B	4.17B	4.18B
Net Income - (IS)	7B	4.9B	2.06B	4.17B	4.18B
Net Income to Common Incl Extra Items	7B	4.9B	2.06B	4.17B	4.18B
Net Income to Common Excl. Extra Items	7B	4.9B	2.06B	4.17B	4.18B
Per Share Items
Net EPS - Basic	43.7	31.61	13.57	28.39	29.14
Basic EPS - Continuing Operations	43.7	31.61	13.57	28.39	29.14
Basic Weighted Average Shares Outstanding	160M	155M	152M	147M	144M
Net EPS - Diluted	43.54	31.47	13.53	28.34	29.08
Diluted EPS - Continuing Operations	43.54	31.47	13.53	28.34	29.08
Diluted Weighted Average Shares Outstanding	161M	156M	152M	147M	144M
Normalized Basic EPS	27.34	23.55	9.28	21.33	20.87
Normalized Diluted EPS	27.24	23.44	9.25	21.28	20.83
Dividend Per Share	6.16	6.76	7.34	8.05	8.99
Payout Ratio	14.03	21.49	54.28	28.41	30.92
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	8.73B	7.68B	3.98B	6.84B	6.82B
EBITA	7.7B	6.54B	2.72B	5.53B	5.39B
EBIT	7.5B	6.34B	2.64B	5.47B	5.35B
EBITDAR	9.16B	8.1B	4.46B	7.31B	7.33B
Total Revenues (As Reported)	35.67B	36.6B	39.29B	41.03B	41.95B
Effective Tax Rate - (Ratio)	21.63	16.11	12.36	16.79	17.48
Current Domestic Taxes	1.4B	1.29B	949M	628M	298M
Current Foreign Taxes	6M	3M	15M	13M	22M
Total Current Taxes	1.4B	1.29B	964M	641M	320M
Deferred Domestic Taxes	518M	-353M	-670M	204M	555M
Deferred Foreign Taxes	11M	1M	-4M	-3M	11M
Total Deferred Taxes	529M	-352M	-674M	201M	566M
Normalized Net Income	4.38B	3.65B	1.41B	3.14B	3B
Non-Cash Pension Expense	-3.39B	-2.77B	-88M	-1.11B	-1.06B
Supplemental Operating Expense Items
General and Administrative Expenses	3.6B	3.87B	4.01B	3.99B	4.03B
Research And Development Expense From Footnotes	1.1B	-	1.2B	1.1B	1.1B
Net Rental Expense, Total	426M	418M	475M	470M	512M
Imputed Operating Lease Interest Expense	121M	114M	133M	136M	150M
Imputed Operating Lease Depreciation	305M	304M	342M	334M	362M
Stock-Based Comp., Other (Total)	94M	99M	87M	101M	119M
Total Stock-Based Compensation	94M	99M	87M	101M	119M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.53B	2.58B	3.11B	4.35B	4.4B
Total Cash And Short Term Investments	3.53B	2.58B	3.11B	4.35B	4.4B
Accounts Receivable, Total	6.96B	7.49B	7.15B	7.18B	7.92B
Other Receivables	571M	850M	1.5B	517M	924M
Total Receivables	7.53B	8.34B	8.65B	7.7B	8.84B
Inventory	811M	978M	1.11B	1.46B	1.31B
Prepaid Expenses	373M	409M	635M	583M	543M
Other Current Assets, Total	182M	180M	206M	186M	189M
Total Current Assets	12.43B	12.49B	13.71B	14.27B	15.29B
Gross Property Plant And Equipment	16.37B	17.87B	19.44B	21.04B	22.48B
Accumulated Depreciation	-6.82B	-7.26B	-7.96B	-8.73B	-9.65B
Net Property Plant And Equipment	9.55B	10.61B	11.47B	12.31B	12.83B
Long-term Investments	418M	332M	339M	347M	483M
Goodwill	17.52B	17.52B	17.52B	17.51B	17.44B
Other Intangibles, Total	578M	384M	305M	254M	208M
Deferred Tax Assets Long-Term	200M	162M	1.02B	1.6B	1.05B
Deferred Charges Long-Term	304M	306M	312M	321M	313M
Other Long-Term Assets, Total	1.59B	1.96B	1.87B	2.75B	3.77B
Total Assets	42.58B	43.76B	46.54B	49.36B	51.38B
Liabilities
Accounts Payable, Total	2.2B	2.59B	2.11B	2.6B	3.24B
Accrued Expenses, Total	2.2B	2.26B	2.47B	2.47B	2.51B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	6M	1.07B	70M	1.58B	534M
Current Portion of Leases	284M	299M	300M	324M	331M
Unearned Revenue Current, Total	3.03B	3.61B	4.19B	4.07B	4.09B
Other Current Liabilities	1.82B	1.76B	2.8B	3.09B	3.18B
Total Current Liabilities	9.53B	11.59B	11.94B	14.13B	13.88B
Long-Term Debt	12.78B	11.8B	13.79B	14.69B	15.16B
Long-Term Leases	1.59B	1.82B	1.89B	1.8B	1.86B
Pension & Other Post Retirement Benefits	3.27B	1.19B	1.29B	1.12B	1.11B
Deferred Tax Liability Non Current	490M	132M	-	-	-
Other Non Current Liabilities	2B	1.91B	2.84B	2.33B	2.69B
Total Liabilities	29.65B	28.44B	31.75B	34.07B	34.7B
Common Stock, Total	156M	153M	150M	145M	142M
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	12.91B	15.31B	14.77B	15.3B	16.66B
Comprehensive Income and Other	-143M	-153M	-128M	-152M	-126M
Total Common Equity	12.93B	15.31B	14.8B	15.29B	16.67B
Total Equity	12.93B	15.31B	14.8B	15.29B	16.67B
Total Liabilities And Equity	42.58B	43.76B	46.54B	49.36B	51.38B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	156M	153M	150M	145M	142M
ECS Total Common Shares Outstanding	156M	153M	150M	145M	142M
Book Value / Share	82.71	99.98	98.56	105.48	117.42
Tangible Book Value	-5.17B	-2.59B	-3.03B	-2.48B	-971M
Tangible Book Value Per Share	-33.06	-16.9	-20.17	-17.08	-6.84
Total Debt	14.66B	15B	16.05B	18.4B	17.88B
Net Debt	10.71B	12.09B	12.6B	13.7B	13B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.65B	147M	192M	-777M	-1.7B
Debt Equivalent Oper. Leases	3.41B	3.34B	3.8B	3.76B	4.1B
Account Code - Inventory Valuation	6	-	6	6	6
Inventories - Raw Materials, Total	-	-	338M	293M	306M
Inventories - Work In Process, Total	478M	574M	719M	1.12B	945M
Inventories - Finished Goods, Total	333M	404M	52M	44M	58M
Land - (BS)	636M	741M	742M	782M	792M
Buildings, Total	3.02B	3.27B	3.6B	4.03B	4.28B
Machinery, Total	8.06B	8.77B	9.64B	10.39B	10.93B
Full Time Employees	88K	95K	101K	97K	95K
Accumulated Allowance for Doubtful Accounts (Supple)	34M	8M	6M	5M	5M
Order Backlog	76.05B	78.74B	84.23B	91.47B	95.68B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	7B	4.9B	2.06B	4.17B	4.18B
Depreciation & Amortization - CF	1.04B	1.14B	1.26B	1.31B	1.43B
Amortization of Goodwill and Intangible Assets - (CF)	204M	197M	80M	57M	45M
Depreciation & Amortization, Total	1.24B	1.34B	1.34B	1.37B	1.47B
(Gain) Loss From Sale Of Asset	-1.98B	-	-	-	-231M
Stock-Based Compensation (CF)	94M	99M	87M	101M	119M
Other Operating Activities, Total	-2.97B	-2.84B	538M	-1.53B	78M
Change In Accounts Receivable	-424M	-690M	301M	-33M	-862M
Change In Inventories	-52M	-205M	-220M	-358M	97M
Change In Accounts Payable	376M	572M	519M	-513M	646M
Change in Unearned Revenues	-	-	-	-	19M
Change In Income Taxes	215M	-279M	-658M	1.14B	-559M
Change in Other Net Operating Assets	66M	2M	-86M	35M	-204M
Cash from Operations	3.57B	2.9B	3.88B	4.39B	4.76B
Capital Expenditure	-1.42B	-1.44B	-1.78B	-1.77B	-1.45B
Sale of Property, Plant, and Equipment	84M	155M	-	-	-
Cash Acquisitions	-	-	-	-	-
Divestitures	3.4B	-	-	-	333M
Investment in Marketable and Equity Securities, Total	-	-	197M	-	-
Other Investing Activities, Total	-11M	39M	-4M	18M	-38M
Cash from Investing	2.06B	-1.24B	-1.58B	-1.75B	-1.16B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	2B	2.5B	998M
Total Debt Issued	-	-	2B	2.5B	998M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-2.24B	-	-1.05B	-	-1.5B
Total Debt Repaid	-2.24B	-	-1.05B	-	-1.5B
Repurchase of Common Stock	-3.74B	-1.55B	-1.55B	-2.57B	-1.66B
Common Dividends Paid	-983M	-1.05B	-1.12B	-1.19B	-1.29B
Common & Preferred Stock Dividends Paid	-983M	-1.05B	-1.12B	-1.19B	-1.29B
Other Financing Activities, Total	-44M	-7M	-38M	-132M	-94M
Cash from Financing	-7B	-2.61B	-1.76B	-1.4B	-3.55B
Net Change in Cash	-1.38B	-953M	532M	1.24B	50M
Supplemental Items
Cash Income Tax Paid (Refund)	1.3B	1.5B	1.2B	880M	731M
Levered Free Cash Flow	6.46B	3.61B	1.63B	4.06B	2.9B
Unlevered Free Cash Flow	6.81B	3.93B	1.97B	4.45B	3.32B
Change In Net Working Capital	-2.21B	39M	-670M	-1.33B	168M
Net Debt Issued / Repaid	-2.24B	-	945M	2.5B	-502M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.76	9.18	3.66	7.13	6.64
Return on Total Capital	17.11	13.68	5.41	10.59	9.8
Return On Equity %	59.6	34.68	13.66	27.75	26.17
Return on Common Equity	59.6	34.68	13.66	27.75	26.17
Margin Analysis
Gross Profit Margin %	20.38	20.42	16.67	20.38	19.81
SG&A Margin	-0.64	3.1	9.94	7.05	7.07
EBITDA Margin %	24.49	20.98	10.14	16.67	16.26
EBITA Margin %	21.59	17.85	6.94	13.47	12.85
EBIT Margin %	21.01	17.32	6.73	13.33	12.75
Income From Continuing Operations Margin %	19.64	13.38	5.23	10.17	9.97
Net Income Margin %	19.64	13.38	5.23	10.17	9.97
Net Avail. For Common Margin %	19.64	13.38	5.23	10.17	9.97
Normalized Net Income Margin	12.29	9.97	3.58	7.64	7.14
Levered Free Cash Flow Margin	18.11	9.87	4.16	9.89	6.91
Unlevered Free Cash Flow Margin	19.09	10.73	5.02	10.84	7.9
Asset Turnover
Asset Turnover	0.82	0.85	0.87	0.86	0.83
Fixed Assets Turnover	3.93	3.63	3.56	3.45	3.34
Receivables Turnover (Average Receivables)	5.25	5.06	5.37	5.73	5.56
Inventory Turnover (Average Inventory)	36.18	32.56	31.37	25.48	24.34
Short Term Liquidity
Current Ratio	1.3	1.08	1.15	1.01	1.1
Quick Ratio	1.16	0.94	0.98	0.85	0.95
Operating Cash Flow to Current Liabilities	0.37	0.25	0.32	0.31	0.34
Days Sales Outstanding (Average Receivables)	69.59	72.06	68.01	63.9	65.68
Days Outstanding Inventory (Average Inventory)	10.09	11.21	11.63	14.36	14.99
Average Days Payable Outstanding	25.68	29.8	26.08	26.1	31.81
Cash Conversion Cycle (Average Days)	54	53.47	53.56	52.16	48.86
Long Term Solvency
Total Debt/Equity	113.39	97.96	108.47	120.31	107.26
Total Debt / Total Capital	53.14	49.49	52.03	54.61	51.75
LT Debt/Equity	111.15	89.01	105.97	107.85	102.07
Long-Term Debt / Total Capital	52.09	44.96	50.83	48.95	49.25
Total Liabilities / Total Assets	69.64	65.01	68.21	69.02	67.55
EBIT / Interest Expense	13.48	12.53	4.85	8.81	8.04
EBITDA / Interest Expense	16.47	16	8.18	11.77	11.03
(EBITDA - Capex) / Interest Expense	13.93	13.17	4.92	8.92	8.85
Total Debt / EBITDA	1.6	1.85	3.6	2.52	2.44
Net Debt / EBITDA	1.17	1.49	2.83	1.87	1.77
Total Debt / (EBITDA - Capex)	1.89	2.25	5.98	3.32	3.04
Net Debt / (EBITDA - Capex)	1.38	1.81	4.7	2.47	2.21
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.08	2.62	7.34	4.44	2.24
Gross Profit, 1 Yr. Growth %	-2.81	2.83	-12.35	27.64	-0.59
EBITDA, 1 Yr. Growth %	58.92	-12.07	-48.14	71.7	-0.28
EBITA, 1 Yr. Growth %	71.43	-15.12	-58.3	102.79	-2.41
EBIT, 1 Yr. Growth %	77.23	-15.44	-58.27	106.77	-2.21
Earnings From Cont. Operations, 1 Yr. Growth %	119.66	-30.11	-58.01	103.02	0.19
Net Income, 1 Yr. Growth %	119.66	-30.11	-58.01	103.02	0.19
Normalized Net Income, 1 Yr. Growth %	88.09	-16.77	-61.46	123.03	-4.47
Diluted EPS Before Extra, 1 Yr. Growth %	128.8	-27.72	-57.01	109.46	2.61
Accounts Receivable, 1 Yr. Growth %	4.79	7.69	-4.63	0.46	10.29
Inventory, 1 Yr. Growth %	6.85	20.59	13.39	31.2	-10.03
Net Property, Plant and Equip., 1 Yr. Growth %	10.98	11.12	8.1	7.28	4.27
Total Assets, 1 Yr. Growth %	-4.25	2.76	6.37	6.05	4.09
Tangible Book Value, 1 Yr. Growth %	-33.09	-49.91	16.96	-18.2	-60.78
Common Equity, 1 Yr. Growth %	22.19	18.46	-3.38	3.35	9.05
Cash From Operations, 1 Yr. Growth %	-17.14	-18.67	33.57	13.24	8.41
Capital Expenditures, 1 Yr. Growth %	-0.35	1.41	23.69	-0.45	-17.94
Levered Free Cash Flow, 1 Yr. Growth %	793	-44.09	-54.8	148.7	-28.57
Unlevered Free Cash Flow, 1 Yr. Growth %	522.27	-42.3	-49.77	125.44	-25.46
Dividend Per Share, 1 Yr. Growth %	8.64	9.74	8.58	9.67	11.68
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.66	-0.27	4.96	5.88	3.33
Gross Profit, 2 Yr. CAGR %	0.06	-0.03	-5.06	5.77	12.65
EBITDA, 2 Yr. CAGR %	43.63	18.21	-32.47	-5.63	30.85
EBITA, 2 Yr. CAGR %	52.72	20.63	-40.51	-8.04	40.68
EBIT, 2 Yr. CAGR %	58.88	22.42	-40.59	-7.11	42.19
Earnings From Cont. Operations, 2 Yr. CAGR %	76.52	23.91	-45.82	-7.67	42.62
Net Income, 2 Yr. CAGR %	76.52	23.91	-45.82	-7.67	42.62
Normalized Net Income, 2 Yr. CAGR %	65.89	25.12	-43.37	-7.29	45.97
Diluted EPS Before Extra, 2 Yr. CAGR %	81.48	28.6	-44.26	-5.1	46.6
Accounts Receivable, 2 Yr. CAGR %	2.22	6.23	1.34	-2.12	5.26
Inventory, 2 Yr. CAGR %	1.77	13.51	16.94	21.97	8.64
Net Property, Plant and Equip., 2 Yr. CAGR %	6.47	11.05	9.6	7.69	5.76
Total Assets, 2 Yr. CAGR %	1.8	-0.81	4.55	6.21	5.06
Tangible Book Value, 2 Yr. CAGR %	-31.24	-42.11	-23.46	-2.19	-43.36
Common Equity, 2 Yr. CAGR %	21.07	20.31	6.99	-0.07	6.16
Cash From Operations, 2 Yr. CAGR %	-8.89	-17.91	4.23	22.99	10.8
Capital Expenditures, 2 Yr. CAGR %	5.8	0.53	12	10.97	-9.62
Levered Free Cash Flow, 2 Yr. CAGR %	88.43	123.44	-49.73	6.02	33.28
Unlevered Free Cash Flow, 2 Yr. CAGR %	77.97	89.48	-46.17	6.41	29.63
Dividend Per Share, 2 Yr. CAGR %	9.26	9.19	9.16	9.13	10.67
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.83	2.65	2.21	4.78	4.65
Gross Profit, 3 Yr. CAGR %	2.14	0.98	-4.32	4.78	3.61
EBITDA, 3 Yr. CAGR %	20.41	21.96	-10.18	-7.83	-3.88
EBITA, 3 Yr. CAGR %	20.45	25.56	-15.34	-10.47	-6.2
EBIT, 3 Yr. CAGR %	21.27	28.76	-14.48	-9.97	-5.5
Earnings From Cont. Operations, 3 Yr. CAGR %	29.45	29.62	-13.61	-15.85	-5.12
Net Income, 3 Yr. CAGR %	29.45	29.62	-13.61	-15.85	-5.12
Normalized Net Income, 3 Yr. CAGR %	22.97	31.82	-15.5	-10.57	-6.36
Diluted EPS Before Extra, 3 Yr. CAGR %	33.04	33.52	-10.75	-13.34	-2.6
Accounts Receivable, 3 Yr. CAGR %	2.44	4.01	2.48	1.05	1.86
Inventory, 3 Yr. CAGR %	7.44	7.69	13.47	21.51	10.2
Net Property, Plant and Equip., 3 Yr. CAGR %	14.44	8	10.06	8.82	6.54
Total Assets, 3 Yr. CAGR %	4.18	2.12	1.53	5.05	5.5
Tangible Book Value, 3 Yr. CAGR %	-24.19	-38.13	-26.81	-21.75	-27.88
Common Equity, 3 Yr. CAGR %	16.44	20.19	11.83	5.76	2.88
Cash From Operations, 3 Yr. CAGR %	-2.32	-12.27	-3.45	7.15	17.92
Capital Expenditures, 3 Yr. CAGR %	4.25	4.32	7.72	7.69	0.35
Levered Free Cash Flow, 3 Yr. CAGR %	133.48	25.68	31.16	-14.35	-7.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	99.39	22.26	21.72	-13.23	-5.5
Dividend Per Share, 3 Yr. CAGR %	9.44	9.42	8.99	9.33	9.97
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.62	7.08	5.48	3.93	2.66
Gross Profit, 5 Yr. CAGR %	4.23	4.74	-0.8	2.87	2.14
EBITDA, 5 Yr. CAGR %	20.81	9.28	-4.46	10.06	4.41
EBITA, 5 Yr. CAGR %	21.12	7.91	-9.16	10.85	3.73
EBIT, 5 Yr. CAGR %	20.6	7.31	-8.85	13	4.81
Earnings From Cont. Operations, 5 Yr. CAGR %	27.95	11.28	-8.63	13.18	5.57
Net Income, 5 Yr. CAGR %	27.95	11.28	-8.63	13.18	5.57
Normalized Net Income, 5 Yr. CAGR %	21.2	6.65	-9.82	14.51	5.15
Diluted EPS Before Extra, 5 Yr. CAGR %	30.92	14.01	-6.06	16.48	8.85
Accounts Receivable, 5 Yr. CAGR %	16.1	10.65	2	1.52	3.58
Inventory, 5 Yr. CAGR %	-0.12	19.7	11.14	13.19	11.52
Net Property, Plant and Equip., 5 Yr. CAGR %	21.62	20.22	12.48	7.88	8.32
Total Assets, 5 Yr. CAGR %	10.7	4.49	4.33	3.74	2.93
Tangible Book Value, 5 Yr. CAGR %	-6.56	-13.6	-23.9	-25.69	-33.95
Common Equity, 5 Yr. CAGR %	19.7	16.51	12.56	11.63	9.53
Cash From Operations, 5 Yr. CAGR %	4.86	2.11	0.25	0.42	2.02
Capital Expenditures, 5 Yr. CAGR %	8.99	9.11	7.28	6.93	0.42
Levered Free Cash Flow, 5 Yr. CAGR %	38.93	15.48	26.32	17.41	32
Unlevered Free Cash Flow, 5 Yr. CAGR %	36.51	14.64	18.1	15.65	24.82
Dividend Per Share, 5 Yr. CAGR %	11.97	11.63	9.32	9.3	9.66